Cover Image

The Progression of NUS1‐Associated Parkinson's Disease and the Diagnostic Potential of Plasma NgBR

Fuente: Wiley Open Access

Saved in:

Bibliographic Details
Main Authors:	Lizhi Li, Juanjuan Huang, Yaqin Xiang, Xuxiang Zhang, Qian Xu, Qiying Sun, Zhenhua Liu, Xinxiang Yan, Jinchen Li, Beisha Tang, Jifeng Guo
Format:	Artículo Open Access
Published:	Wiley 2025
Subjects:	CNS Neuroscience & Therapeutics
Online Access:	Acceder al recurso
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Genetic Analysis of Neurite Outgrowth Inhibitor‐Associated Genes in Parkinson's Disease: A Cross‐Sectional Cohort Study
by: Xiurong Huang, et al.
Published: (2024)

Exploratory Analysis of the Association Between Plasma Ceramide Alterations and Cognitive Dysfunction in Parkinson's Disease
by: Xu Liu, et al.
Published: (2024)

Alpinetin Targets Mitophagy Pathways to Mitigate Parkinson's Disease Progression
by: Zilu Shen, et al.
Published: (2025)

Electrophysiological Alterations in the Progression of Parkinson's Disease and the Therapeutic Effect of Tetrabenazine on Rats With Levodopa‐Induced Dyskinesia
by: Yuewei Bi, et al.
Published: (2025)

Unraveling the Relation of Parkinson's Disease and Metabolites: A Combined Analysis of Stool and Plasma Metabolites Based on Untargeted Metabolomics Technology
by: Sufang Liu, et al.
Published: (2025)

Predicting Long‐Term Depression Progression in Parkinson's Disease: A Machine‐Learning Survival Analysis and Risk Score
by: Defu Liu, et al.
Published: (2026)

Exploring the Fecal Microbiome Dysbiosis and Its Plasma Metabolome Determinants in Advanced Parkinson's Disease With Motor Complications
by: Shuangjie Qian, et al.
Published: (2026)

What We Know About TMEM175 in Parkinson's Disease
by: Jing Wang, et al.
Published: (2025)

Novel Insights Into the Association Between Parkinson's Disease and Constipation: Role of SHMT2 as a Promising Biomarker
by: Jiehua Su, et al.
Published: (2026)

Nonmotor Symptom Changes and Their Association With Falls Among Parkinson's Disease Patients Undergoing Deep Brain Stimulation: A 1‐Year Cohort Study
by: Ying Gao, et al.
Published: (2025)

GSDMD ‐Deficient G‐ MDSCs Exert Profoundly Suppressive Activity to Relieve MPTP ‐Induced Parkinson's Disease
by: Qi Wu, et al.
Published: (2025)

Histamine Modulation of the Basal Ganglia Circuitry in the Motor Symptoms of Parkinson's Disease
by: Hui‐Xian Zhu, et al.
Published: (2025)

Static and Dynamic Functional Network Connectivity in Parkinson's Disease Patients With Postural Instability and Gait Disorder
by: Bo Shen, et al.
Published: (2024)

Multi‐Target Repetitive Transcranial Magnetic Stimulation Improves Freezing of Gait in Parkinson's Disease: A Randomized Controlled Trial
by: Zixuan Zhang, et al.
Published: (2025)

Data‐Driven Subtypes of Parkinson Disease Based on Dopamine Responsiveness
by: Jian‐Yong Wang, et al.
Published: (2025)

SMPD1 as a Potential Prognostic Biomarker in Glioma Is Associated With an Immunosuppressive Microenvironment
by: Yanan Xu, et al.
Published: (2026)

SYNGR3 Accelerates α‐Synuclein Aggregation and Neurodegeneration in Parkinson's Disease
by: Xin Wang, et al.
Published: (2026)

Monoamine Loss and Functional Connectivity Alterations in Patients With Parkinson's Disease and Depression
by: Bao‐Lei Xu, et al.
Published: (2025)

Groundbreaking Insights Into SIRT1 / NRF2 ‐Mediated Ferroptosis Inhibition by Resveratrol in Parkinson's Disease Models
by: Qian Zheng, et al.
Published: (2025)

Mitochondria‐Associated Endoplasmic Reticulum Membranes as Potential Therapeutic Targets in Epilepsy
by: Huaiyu Sun, et al.
Published: (2025)

Dual Role of Exosomes in Parkinson's Disease: Adenine Exerts a Beneficial Effect
by: Lei Chen, et al.
Published: (2025)

Anatomical Determinants of STN Coordinate Shift in Idiopathic Parkinson's Disease DBS Surgery
by: Ozan Hasimoglu, et al.
Published: (2025)

Levodopa and Plant‐Derived Bioactive Compounds in Parkinson's Disease: Mechanisms, Efficacy, and Future Perspectives
by: Emre Aktaş, et al.
Published: (2025)

Novel Insights Into the Causal Effects and Shared Genetics Between Body Fat and Parkinson Disease
by: Qian Zhao, et al.
Published: (2024)

Association between plasma Netrin‐1 levels and motor and nonmotor symptoms in Parkinson's disease
by: Ye Hua, et al.
Published: (2024)

Identification of Common Brain Protein and Genetic Loci Between Parkinson's Disease and Lewy Body Dementia
by: Tingting Jia, et al.
Published: (2025)

Identifying Risk Factors and Constructing Predictive Models for Wearing‐Off and Dyskinesia in Chinese Patients With Parkinson's Disease on Long‐Term Levodopa Therapy
by: Jing Zhao, et al.
Published: (2025)

Steroids' Neuroprotective Potential in Severe Cerebral Venous Thrombosis: Experimental and Clinical Exploration of NLRP3 Inflammasome Inhibition
by: Shuyuan Hu, et al.
Published: (2024)

Plasma Metabolites Link Non‐Communicable Diseases to Increased White Matter Hyperintensities
by: Nan Wang, et al.
Published: (2025)

High‐Intensity Alternating Current Stimulation as an Add‐On to Multidisciplinary Intensive Rehabilitation for Parkinson's Disease: A Randomized Controlled Trial
by: Ting‐ting Hou, et al.
Published: (2026)

Upregulated PKM2 Protects Dopaminergic Neurons From Oxidative Damage Through Nrf2 Transactivation in an MPTP ‐Induced Mouse Model of Parkinson's Disease
by: Meng Mei, et al.
Published: (2026)

Da‐Bu‐Yin‐Wan and Qian‐Zheng‐San Alleviate Parkinson's Disease by Activating the Keap1/Nrf2/ HO ‐1 Pathway to Positively Regulate Oxidative Stress
by: Huimin Zhu, et al.
Published: (2025)

Association Between Renal Dysfunction and Cerebral Small Vessel Disease: A Prospective Cohort Study From the UK Biobank
by: Xiaowei Sun, et al.
Published: (2026)

Brain Alterations Linked to the MPTP Mouse Model of Parkinson's Disease Uncovered by Diffusion Kurtosis Imaging and Magnetic Resonance Spectroscopy
by: Ajay Modi, et al.
Published: (2026)

Development of In Vitro Parkinson's Disease Model Mediated by MPP + and α‐Synuclein Using Wharton's Jelly Mesenchymal Stem Cells
by: Naisarg Gamit, et al.
Published: (2025)

Alterations in cortical volume and complexity in Parkinson's disease with depression
by: Jiaying Yuan, et al.
Published: (2024)

Insulin‐Like Growth Factor Binding Protein 2 Drives Neurodegeneration in Parkinson's Disease: Insights From In Vivo and In Vitro Studies
by: Jing An, et al.
Published: (2024)

Amyloid Beta in Alzheimer's Disease: Mechanisms, Biomarker Potential, and Therapeutic Targets
by: Shamseddin Ahmadi, et al.
Published: (2025)

Association of Sleep Duration With Intracranial Atherosclerosis and Cerebral Small Vessel Disease: A Mediation by Metabolic Factors
by: Hongbin Chen, et al.
Published: (2026)

Respiratory Variability in Disorders of Consciousness: Relationship and Clinical Applications
by: Yongli Wu, et al.
Published: (2026)